Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA optimistic about enactment of PDUFA/FDA modernization package -- Holmer.

Executive Summary

PHRMA OPTIMISTIC ABOUT ENACTMENT OF "FDA MODERNIZATION"/PDUFA PACKAGE, Pharmaceutical Research & Manufacturers of America President Alan Holmer indicated at an April 15 briefing in Washington, D.C. Holmer noted that Senate Labor Committee ranking Democrat Edward Kennedy (D-Mass.), HHS Secretary Shalala and the Patients' Coalition -- parties who have all opposed the linkage of FDA reform legislation to reauthorization of the Prescription Drug User Fee Act -- have each expressed a recent willingness to "accept consensus or non-controversial FDA modernization items as amendments to PDUFA."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel